NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

SANA

Sana Biotechnology Inc

Jul 01 • 11:25AM ET

2.82

Dollar change +0.09
Percentage change 3.11	%

Healthcare • Biotechnology • USA • NASD

Peers: VERV PRME NTLA EDIT TSHA CRBU CABA BEAM MGTX PGEN

| Held by: IWM VTI VXF IWN IBB SCHA VTWO SMLF VHT PRFZ

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.88	Insider Own	44.39%	Shs Outstand	225.46M	Perf Week	-5.22%
Market Cap	634.94M	Forward P/E	-	EPS next Y	-0.71	Insider Trans	-0.29%	Shs Float	125.44M	Perf Month	29.72%
Enterprise Value	617.35M	PEG	-	EPS next Q	-0.20	Inst Own	51.55%	Short Float	34.73%	Perf Quarter	67.56%
Income	-208.67M	P/S	-	EPS this Y	34.68%	Inst Trans	-6.46%	Short Ratio	10.57	Perf Half Y	65.59%
Sales	0.00M	P/B	3.04	EPS next Y	6.84%	ROA	-37.04%	Short Interest	43.56M	Perf YTD	72.70%
Book/sh	0.93	P/C	5.83	EPS next 5Y	14.07%	ROE	-71.44%	52W High	7.40 -61.96%	Perf Year	-47.87%
Cash/sh	0.48	P/FCF	-	EPS past 3/5Y	18.55% -10.60%	ROIC	-72.61%	52W Low	1.26 123.41%	Perf 3Y	-59.84%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.13% 10.53%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	42.12%	Oper. Margin	-	ATR (14)	0.25	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.40	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	58.93	Recom	1.29
Dividend Gr. 3/5Y	- -	Current Ratio	3.40	EPS Q/Q	57.97%	SMA20	4.23%	Beta	1.86	Target Price	8.20
Payout	-	Debt/Eq	0.44	Sales Q/Q	-	SMA50	27.61%	Rel Volume	1.31	Prev Close	2.73
Employees	194	LT Debt/Eq	0.37	Earnings	May 08 AMC	SMA200	3.36%	Avg Volume	4.12M	Price	2.82
IPO	Feb 04, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	4.24% -	Trades		Volume	1,780,720	Change	3.11%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-18-25	Upgrade	Citizens JMP	Mkt Perform → Mkt Outperform	$5
Mar-14-25	Initiated	Jefferies	Buy	$7
Jan-08-25	Upgrade	TD Cowen	Hold → Buy
Nov-05-24	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Jun-26-24	Initiated	Rodman & Renshaw	Buy	$16
Jan-16-24	Upgrade	H.C. Wainwright	Neutral → Buy	$12
Sep-25-23	Initiated	JMP Securities	Mkt Outperform	$9
Sep-05-23	Initiated	Citigroup	Buy	$8
Aug-14-23	Initiated	TD Cowen	Market Perform
May-02-23	Initiated	H.C. Wainwright	Neutral
Mar-01-21	Initiated	Morgan Stanley	Overweight	$40
Mar-01-21	Initiated	JP Morgan	Neutral	$35
Mar-01-21	Initiated	Goldman	Neutral	$40
Mar-01-21	Initiated	BofA Securities	Buy	$45

Show Previous Ratings

Jun-24-25 03:51PM	BofA Remains Bullish on Sana Biotechnology (SANA) (Insider Monkey) +14.23%
Jun-23-25 10:05AM	Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression (GlobeNewswire)
Jun-09-25 04:05PM	Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions (GlobeNewswire)
May-28-25 04:05PM	Sana Biotechnology to Present at June 2025 Investor Conferences (GlobeNewswire) +12.50%
May-12-25 04:05PM	Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference (GlobeNewswire) +9.89% -10.25%
04:42PM	Loading…
May-08-25 04:42PM	Sana: Q1 Earnings Snapshot (Associated Press Finance) +6.47%
04:05PM	Sana Biotechnology Reports First Quarter 2025 Financial Results and Business Updates (GlobeNewswire)
May-06-25 10:12PM	Flagship Pioneering, the National University of Singapore, National University Hospital and the National University Health System Announce Collaboration to Advance Biotech Research & Development (PR Newswire) -8.56%
Apr-29-25 08:00AM	Flagship Pioneering Appoints Rahul Kakkar as CEO-Partner and CEO of Quotient Therapeutics (PR Newswire)
Apr-24-25 06:00AM	Flagship Pioneering Unveils Etiome to Pioneer Preemptive Healthcare (PR Newswire)
Apr-22-25 05:45AM	Sana Biotechnology, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your Rights - SANA (PR Newswire) +8.81%
Apr-21-25 12:56PM	Sana Biotechnology, Inc. Sued for Securities Law Violations Investors Should Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your Rights SANA (GlobeNewswire)
Apr-16-25 11:23AM	Is Sana Biotechnology Inc. (NASDAQ:SANA) the Best Biotech Penny Stock to Buy According to Hedge Funds? (Insider Monkey) -7.06%
Apr-10-25 12:39PM	Investors in Sana Biotechnology, Inc. Should Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your Rights SANA (GlobeNewswire)
Apr-01-25 08:00AM	Flagship Pioneering Announces Agreement Between Pioneering Medicines and Pfizer to Discover Potential Novel, Selective Inhibitors for Autoimmune Disease (PR Newswire) -10.71%
08:00AM	Loading…
Mar-25-25 08:00AM	Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica, an AI-Powered Drug Discovery Platform (Business Wire) -11.16%
Mar-24-25 11:45PM	Sana Biotechnology: High-Risk High-Reward With Breakthrough UP421 (SeekingAlpha)
Mar-17-25 04:14PM	Sana: Q4 Earnings Snapshot (Associated Press Finance) -5.46% -17.69%
04:05PM	Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates (GlobeNewswire)
Mar-04-25 04:04PM	Is Sana Biotechnology (SANA) Among Jeff Bezos Investments in 2025? (Insider Monkey) +5.35%
Mar-01-25 06:02PM	Why Sana Biotechnology, Inc. (SANA) is Skyrocketing So Far in 2025 (Insider Monkey)
Feb-24-25 04:05PM	Sana Biotechnology to Present at the Cowen 45th Annual Health Care Conference (GlobeNewswire) -10.07%
Jan-28-25 10:42AM	Sana Biotechnology, Inc. (SANA): A Bull Case Theory (Insider Monkey)
Jan-22-25 07:59AM	Is Sana Biotechnology, Inc. (SANA) the Hottest Smid-Cap Stock So Far In 2025? (Insider Monkey) +19.86%
Jan-08-25 04:05PM	Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +160.61% -14.88%
10:34AM	Sana Biotechnology (SANA), eBay (EBAY) Are Among Todays Big Winners (Insider Monkey)
10:11AM	This Biotech Stock Soared 300% Overnight. Why It Can Go Higher. (Barrons.com)
07:26AM	Sana Biotechnology price target lowered to $7 from $8 at BofA (TipRanks)
07:25AM	This Biotech Stock Just Soared 240%. Why It Can Go Higher. (Barrons.com)
06:31AM	Tenvie raises $200M for brain drug R&D; Sana spikes on single patients results (BioPharma Dive)
04:05PM	Loading…
Jan-07-25 04:05PM	Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression (GlobeNewswire) -5.71%
Dec-02-24 09:00AM	Sana Biotechnology Announces Fast Track Designation for SC291 in Relapsed/Refractory Systemic Lupus Erythematosus (GlobeNewswire)
Nov-25-24 04:05PM	Sana Biotechnology to Present at December 2024 Investor Conferences (GlobeNewswire)
Nov-20-24 08:00AM	Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies (PR Newswire) +7.20%
06:30AM	Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer (PR Newswire)
Nov-13-24 09:55AM	Here's Why Sana (SANA) Could be Great Choice for a Bottom Fisher (Zacks) -6.34%
08:00AM	Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori Bio (PR Newswire)
08:00AM	Brian M. Alexander Joins Valo Health as Chief Executive Officer and Flagship Pioneering as CEO-Partner (PR Newswire)
Nov-11-24 09:35AM	Down -24.69% in 4 Weeks, Here's Why Sana (SANA) Looks Ripe for a Turnaround (Zacks)
Nov-08-24 09:10AM	Sana: Q3 Earnings Snapshot (Associated Press Finance)
09:00AM	Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business Updates (GlobeNewswire)
Nov-05-24 04:40AM	Sana to lay off staff, deepen autoimmune focus in latest retrenchment (BioPharma Dive) -9.84%
Nov-04-24 04:30PM	Sana Biotechnology Announces Increased Focus on Type 1 Diabetes and B-cell Mediated Autoimmune Diseases with the Potential to Deliver Clinical Proof of Concept Data Across Multiple Studies in 2024 and 2025 (GlobeNewswire)
Oct-23-24 08:00AM	Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence (PR Newswire)
Oct-16-24 08:58AM	Why Sana Biotechnology, Inc. (SANA) is the Penny Stock with the Biggest Upside Potential According to Analysts (Insider Monkey)
Oct-13-24 04:48PM	Sana Biotechnology, Inc. (SANA): Jeff Bezos Is Buying This Stock Now (Insider Monkey)
Oct-09-24 07:00AM	Flagship Pioneering Announces Appointment of Paul Parker as Managing Partner, Leading Capital Solutions (PR Newswire)
Oct-03-24 08:00AM	Invaio Sciences Appoints Andr Andonian as Chairman of the Board of Directors (PR Newswire)
Sep-30-24 04:05PM	Sana Biotechnology to Present at the Goldman Sachs Cell Therapy Day Conference (GlobeNewswire)
Sep-26-24 06:00AM	Flagship Pioneering Unveils Mirai Bio to Provide Fully Integrated End-to-End Genetic Medicine Development Capabilities for the Biotech Industry (PR Newswire) +13.56%
Aug-29-24 04:05PM	Sana Biotechnology to Present at September 2024 Investor Conferences (GlobeNewswire)
Aug-28-24 06:30AM	Flagship Pioneering and Quotient Therapeutics Announce Agreement to Identify Potential Novel Targets for the Treatment of Cardiovascular and Renal Diseases under Strategic Partnership with Pfizer (PR Newswire)
Aug-26-24 04:05PM	Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific Officer (GlobeNewswire)
Aug-08-24 05:03PM	Sana: Q2 Earnings Snapshot (Associated Press Finance) +5.36%
04:05PM	Sana Biotechnology Reports Second Quarter 2024 Financial Results and Business Updates (GlobeNewswire)
Aug-06-24 06:30AM	Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner (PR Newswire)
Jul-29-24 07:00AM	GSK and Flagship Pioneering partner to discover novel medicines and vaccines (PR Newswire)
Jul-25-24 08:00AM	Analog Devices and Flagship Pioneering Announce Strategic Partnership to Accelerate the Development of a Fully Digitized Biological World (PR Newswire)
Jul-23-24 06:00AM	Flagship Pioneering Unveils Abiologics to Pioneer Supranatural Biologics, A New Biotherapeutic Class (PR Newswire)
Jul-17-24 08:00AM	Alltrna Announces Updates to Its Board of Directors (PR Newswire) -7.00%
Jul-10-24 06:00AM	Flagship Pioneering Raises $3.6 Billion to Fuel Breakthrough Innovations that Transform Human Health and Sustainability (PR Newswire)
06:00AM	Flagship Pioneering Expands Leadership Team with Key Appointments and Promotions (PR Newswire)
Jun-12-24 07:00AM	Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer (PR Newswire)
May-21-24 09:00AM	Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation as a Treatment for Huntington's Disease and Other Glial-based Neurodegenerative Conditions (GlobeNewswire)
May-16-24 05:23PM	Stanley Druckenmiller Bet On Biotech, Financial Services in Q1, Trimmed Nvidia Stake (Investopedia) -7.77%
May-10-24 01:35PM	Sana Biotechnology Inc (SANA) Reports First Quarter 2024 Financial Results (GuruFocus.com)
May-09-24 07:00AM	Flagship Pioneering and Metaphore Biotechnologies Announce Research Collaboration with Novo Nordisk to Develop Next-Generation Therapeutics for Obesity Management (PR Newswire) -20.97%
May-08-24 10:55PM	SANA Stock Earnings: Sana Biotechnology Meets EPS for Q1 2024 (InvestorPlace) -5.48%
05:22PM	Sana: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Sana Biotechnology Reports First Quarter 2024 Financial Results and Business Updates (GlobeNewswire)
May-06-24 04:05PM	Sana Biotechnology to Present at May and June 2024 Investor Conferences (GlobeNewswire)
Apr-08-24 08:00AM	Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences (PR Newswire)
Mar-19-24 10:00AM	CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB) (GlobeNewswire)
08:30AM	Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024 (PR Newswire)
Mar-11-24 07:00PM	Director Patrick Yang Sells 25,000 Shares of Sana Biotechnology Inc (SANA) (GuruFocus.com)
Mar-07-24 09:01AM	Baillie Gifford Bolsters Stake in Sana Biotechnology Inc (GuruFocus.com)
Feb-29-24 04:55PM	Sana: Q4 Earnings Snapshot (Associated Press Finance) -5.90% +12.25%
04:05PM	Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates (GlobeNewswire)
03:02AM	14 Stocks With Heavy Insider Buying In 2024 (Insider Monkey)
Feb-28-24 04:05PM	Sana Biotechnology to Present at the Cowen 44th Annual Health Care Conference (GlobeNewswire) +7.34%
Feb-13-24 04:05PM	Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHP (GlobeNewswire) +15.15%
Feb-12-24 04:05PM	Sana Biotechnology Announces Closing of Upsized Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
Feb-08-24 01:22AM	Sana Biotechnology Announces Pricing of Upsized Public Offering (GlobeNewswire)
Feb-07-24 04:01PM	Sana Biotechnology Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Jan-27-24 11:02AM	Baillie Gifford Reduces Stake in Sana Biotechnology Inc (GuruFocus.com)
Jan-18-24 12:00PM	Are You Looking for a Top Momentum Pick? Why Sana Biotechnology (SANA) is a Great Choice (Zacks) -7.68%
10:24AM	Sana Bio (SANA) Stock Rallies 105% in 3 Months: Here's Why (Zacks)
Jan-09-24 08:44AM	DEAN BANKS APPOINTED CEO OF INDIGO AG AND CEO-PARTNER OF FLAGSHIP PIONEERING (PR Newswire)
Jan-08-24 06:30AM	Flagship Pioneering Debuts Enabling Technologies Initiative (PR Newswire)
06:30AM	Flagship Pioneering and Samsung Announce Collaboration to Advance Groundbreaking Technologies in Translational Science and Medicine (PR Newswire)
Jan-05-24 09:00AM	Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC262, a Hypoimmune-modified, CD22-directed Allogeneic CAR T Therapy, for Patients with Relapsed or Refractory B-cell Malignancies (GlobeNewswire)
Jan-03-24 04:05PM	Sana Biotechnology to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +11.90%
Dec-19-23 09:01AM	EVP Christian Hordo Sells 75,000 Shares of Sana Biotechnology Inc (SANA) (GuruFocus.com) +13.60%
Dec-11-23 09:00AM	Sana Biotechnology Highlights Preclinical Data Supporting Tumor Control and Immune Evasion Capabilities of Hypoimmune-Modified Allogeneic CAR T Cells in Presentations at the American Society of Hematology Annual Meeting (GlobeNewswire)
Dec-01-23 04:05PM	Sana Biotechnology Publishes Early Clinical Data Showing that SC291, a CD19-directed Allogeneic CAR T Therapy, Evades Immune Detection in Presence of Intact Immune System (GlobeNewswire)
Nov-27-23 07:01PM	Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science Leaders (PR Newswire)
Nov-21-23 09:00AM	Sana Biotechnology to Present at November and December 2023 Investor Conferences (GlobeNewswire) -6.74%
06:00AM	Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics (PR Newswire)
Nov-17-23 09:00AM	Uppsala University Hospital and Sana Biotechnology Announce Authorization of the First-in-Human Clinical Trial Application for a Primary Islet Cell Treatment for Patients with Type 1 Diabetes (GlobeNewswire) +7.14%
Nov-09-23 04:05PM	Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-directed Allogeneic CAR T Therapy, for Patients with Lupus Nephritis, Extrarenal Lupus, and ANCA-associated Vasculitis (GlobeNewswire)

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wyrick Susan D.	See Remarks	Mar 07 '25	Option Exercise	0.00	3,250	0	158,231	Mar 10 08:13 PM
Cassidy Bernard J	EVP & General Counsel	Mar 07 '25	Option Exercise	0.00	11,041	0	115,823	Mar 10 08:12 PM
Harr Steve	President & CEO	Mar 07 '25	Option Exercise	0.00	50,000	0	7,889,750	Mar 10 08:12 PM
Wyrick Susan D.	See Remarks	Mar 02 '25	Option Exercise	0.00	1,525	0	155,471	Mar 03 07:28 PM
CHRISTIAN HORDO & KATHARINE HO	Officer	Feb 18 '25	Proposed Sale	3.16	75,000	237,000		Feb 18 04:27 PM
CHRISTIAN HORDO & KATHARINE HO	Officer	Jan 16 '25	Proposed Sale	3.86	75,000	289,500		Jan 16 04:31 PM
FMR LLC	See Remark 1	Jan 08 '25	Sale	6.49	290,912	1,887,320	4,541,511	Jan 10 01:32 PM
Wyrick Susan D.	See Remarks	Jan 02 '25	Option Exercise	0.00	5,000	0	155,512	Jan 03 04:15 PM
CHRISTIAN HORDO & KATHARINE HO	Officer	Dec 16 '24	Proposed Sale	1.89	75,000	141,750		Dec 16 04:33 PM
Hardy Nathan	Former CFO	Nov 26 '24	Proposed Sale	2.50	91,607	229,018		Nov 26 06:20 PM
NATHAN HARDY	Former CFO	Nov 25 '24	Proposed Sale	2.50	25,933	64,960		Nov 25 05:40 PM
NATHAN HARDY	Officer	Oct 21 '24	Proposed Sale	3.95	45,796	180,807		Oct 21 05:19 PM
Mulligan Richard	Director	Sep 24 '24	Sale	4.08	150,000	612,570	2,848,121	Sep 26 04:07 PM
Mulligan Richard	Director	Sep 25 '24	Sale	3.89	150,000	583,170	2,698,121	Sep 26 04:07 PM
RICHARD MULLIGAN	Director	Sep 25 '24	Proposed Sale	4.09	150,000	613,500		Sep 25 04:20 PM
RICHARD MULLIGAN	Director	Sep 24 '24	Proposed Sale	4.09	150,000	613,500		Sep 24 04:28 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SANA

Sana Biotechnology Inc

Upgrade your FINVIZ experience